{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:34:06Z","timestamp":1774614846615,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"am","delay-in-days":300,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.antiviral.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T12:15:30Z","timestamp":1558440930000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years"],"prefix":"10.1016","volume":"168","author":[{"given":"Pallavi","family":"Surana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devika","family":"Kapuria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carly","family":"Broadwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Takyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc G.","family":"Ghany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil","family":"Ben-Yakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Jake","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.05.007_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clinre.2012.07.003","article-title":"Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results","volume":"37","author":"Ba\u015far","year":"2013","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.antiviral.2019.05.007_bib2","doi-asserted-by":"crossref","first-page":"14568","DOI":"10.3748\/wjg.v20.i40.14568","article-title":"Non-invasive assessment of liver fibrosis in chronic hepatitis B","volume":"20","author":"Branchi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2019.05.007_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.05.007_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12072-015-9614-4","article-title":"Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years","volume":"9","author":"Buti","year":"2015","journal-title":"Hepatol. Int.l"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.05.007_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/liv.12393","article-title":"Hepatitis B: are non-invasive markers of liver fibrosis reliable?","volume":"34","author":"Castera","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2019.05.007_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1055\/s-0030-1262515","article-title":"A patient with chronic hepatitis B and regression of fibrosis during treatment","volume":"30","author":"Chang","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2019.05.007_bib7","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1440-1746.2011.06695.x","article-title":"Natural history of chronic hepatitis B REVEALed","volume":"26","author":"Chen","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2019.05.007_bib8","first-page":"1","article-title":"Improvement of liver fibrosis after long-term antiviral therapy assessed by fibroscan in chronic hepatitis B patients with advanced fibrosis","author":"Chon","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2019.05.007_bib9","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1002\/hep.1840360720","article-title":"The role of liver biopsy in chronic hepatitis C","volume":"36","author":"Dienstag","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.05.007_bib10","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199910213411702","article-title":"Lamivudine as initial treatment for chronic hepatitis B in the United States","volume":"341","author":"Dienstag","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.05.007_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","article-title":"Histological outcome during long-term lamivudine therapy","volume":"124","author":"Dienstag","year":"2003","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.05.007_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/liv.13291","article-title":"Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs)","volume":"37","author":"Grossi","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2019.05.007_bib14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bbadis.2012.11.002","article-title":"Extracellular matrix degradation in liver fibrosis: biochemistry and regulation","volume":"1832","author":"Iredale","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2019.05.007_bib15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.05.007_bib16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1478-3231.2009.02192.x","article-title":"Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients","volume":"30","author":"Kim","year":"2010","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2019.05.007_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.05.007_bib18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa051287","article-title":"Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B","volume":"354","author":"Lai","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.05.007_bib19","article-title":"The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.05.007_bib20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"348","author":"Marcellin","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.05.007_bib21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.05.007_bib22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/135965350400900504","article-title":"Effect of long-term lamivudine in chronic hepatitis B virus-infected children","volume":"9","author":"Ozgenc","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2019.05.007_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/00365513.2015.1125013","article-title":"Aspartate aminotransferase to platelet ratio index - a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues","volume":"76","author":"Peng","year":"2016","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.antiviral.2019.05.007_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-5926-3-8","article-title":"Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C","volume":"3","author":"Poynard","year":"2004","journal-title":"Comp. Hepatol."},{"key":"10.1016\/j.antiviral.2019.05.007_bib25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","article-title":"Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients","volume":"64","author":"Ray Kim","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.05.007_bib27","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jgh.13020","article-title":"Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2years of entecavir treatment","volume":"30","author":"Shin","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2019.05.007_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2017.03.063","article-title":"Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: a preliminary study","volume":"806","author":"Stasi","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.05.007_bib29","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.05.007_bib30","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.05.007_bib31","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.antiviral.2019.05.007_bib32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10620-014-3336-7","article-title":"Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B","volume":"60","author":"Tsai","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.antiviral.2019.05.007_bib33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.05.007_bib34","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.5858\/2000-124-1599-ROHC","article-title":"Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis","volume":"124","author":"Wanless","year":"2000","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.antiviral.2019.05.007_bib35","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/jgh.12718","article-title":"Long-term lamivudine treatment achieves regression of advanced liver fibrosis\/cirrhosis in patients with chronic hepatitis B","volume":"30","author":"Xu","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2019.05.007_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2018.02.037","article-title":"Long-term effects of treatment for chronic HBV infection on patient-reported outcomes","author":"Younossi","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2019.05.007_bib38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2014.10.026","article-title":"Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: results from a multicentre study","volume":"62","author":"Yuen","year":"2015","journal-title":"J. Hepatol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219300488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219300488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:27:56Z","timestamp":1759062476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219300488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":35,"alternative-id":["S0166354219300488"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}